Table 1. Pharmacokinetics of different medications used in the management of hypertensive crises in the elderly.
Medication | Mechanism(s) | Dosage | Onset | Half-life |
Nitroglycerin | Activation of guanylyl cyclase via NO | 5 to 200 µg/min | 2–5 min | 1–4 min |
Nitroprusside | Activation of guanylyl cyclase via NO | 0.3 to 10 mcg/kg/min | < 2 min | –2 min |
Nifedipine | 1st generation dihydropyridine calcium-channel blocker | 10 to 20 mg 3 times daily | –20 min | 2.5–5 h |
Nicardipine | 1st generation dihydropyridine calcium-channel blocker | 5–25 mg/h | 5–15 min | 4–6 h |
Clevidipine | 3rd generation dihydropyridine calcium-channel blocker | 1–2 mg/h Increase every 10 min up to 16 mg/h | 2–4 min | 5–15 min |
Labetalol | Selective α1-adrenergic receptor blocker andnonselective β-adrenergic blocker | 200–400 mg per o.s. every 2–3 h | 30–120 min | 2–6 h |
Esmolol | Beta1 receptor blocker | 0.5–1 mg/kg loading dose.50–300 µg/kg/min infusion | 60 s | 20 min |
Clonidine | Alpha2 adrenergic agonist and imidazoline I1 receptor agonist | 500 µg/kg in bolus and 25–300 µg/kg/min | 30 min | 12–16 h |
Fenoldopam | Dopamine type-1 receptor agonist | 0.05–1.6 µg/Kg/ min | 5–10 min | 5 min |
Hydralazine | Inhibition of calcium influx in vascular smooth muscle cells | 20 mg initial bolus; 20–80 mg repeat boluses | 5–15 min | 3 h |
NO: Nitric oxide.